Isoptin Rr (Verapamil Hydrochloride)

Verapamil hydrochloride blocks L‑type calcium channels in cardiac and vascular smooth muscle. This reduces calcium entry into cells, leading to decreased heart muscle contraction, slower electrical conduction through the AV node, and relaxation of peripheral arteries, which together lower blood pressure and reduce cardiac workload.

The specific dose of Isoptin Rr is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the dosage instructions provided by their healthcare professional and not adjust the dose on their own.

Safety of verapamil during pregnancy or lactation has not been definitively established. Healthcare providers will weigh potential benefits against possible risks before prescribing it to pregnant or nursing individuals. Patients should discuss any concerns with their physician.

To order Isoptin Rr, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and necessary import documentation.

Isoptin Rr (verapamil) is a non‑dihydropyridine calcium channel blocker, primarily affecting cardiac conduction and contractility, whereas dihydropyridine agents like amlodipine mainly cause vascular smooth‑muscle relaxation. Verapamil is often chosen for its antiarrhythmic properties, while others are preferred for pure antihypertensive effects.

Isoptin Rr should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Isoptin Rr is taken orally, usually with a glass of water. The tablet should be swallowed whole and not crushed or chewed unless directed by a healthcare professional. Dosing times (e.g., with or without food) are determined by the prescriber.

Serious risks include severe bradycardia, marked hypotension, heart block, and rare allergic reactions such as anaphylaxis. Patients experiencing fainting, very slow heart rate, chest pain, or signs of an allergic response should seek immediate medical attention.

Isoptin Rr is contraindicated in patients with known hypersensitivity to verapamil or other calcium channel blockers, those with severe sinus bradycardia, second‑ or third‑degree AV block without a pacemaker, and individuals with cardiogenic shock. Clinicians should evaluate each patient’s medical history before prescribing.